BioSpace News Archive

Chronic diseases are long-term clinical conditions that progress over the time. It is considered an expensive and most prevalent health care issue across the globe.

The demand for radio frequency beauty equipment is soaring as there is a greater extent of acceptance of latest and emerging technologies, which act as effective alternatives to traditional methods of improving beauty and appearance.

Subunit vaccines are made by removing the non-immunity producing components of microorganisms and retaining a part, which stimulates the immune system.

Sepsis can be defined as the body’s reaction to the fungal, bacterial, viral, or parasitic infection, which may further lead to systemic inflammatory reaction and organ dysfunction or organ failure.

Superiority of multiplex detection immunoassays over the traditional detection systems based on maintaining the linearity for multiple orders.

Microplate readers are also known as plate readers or microplate photometers. This instrument is used to detect biological, physical, and chemical events of samples in microtiter plates.

Intramedullary nails, also called intramedullary rods, are used in the medullary cavity of bone.

Hyperpigmentation refers to darkening or discoloration of the skin due to higher levels of melanin than normal.

Progenity, Inc., a biotechnology company with an established track record of success in developing and commercializing molecular testing products, announced the pricing of its previously announced underwritten public offering of 7,645,259 shares of its common stock at a public offering price of $3.27 per share.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Marzeptacog alfa (activated) – or MarzAA, the Company’s subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with Hemophilia A or B with inhibitors that will enter a pivotal Phase 3 study CRIMSON 1 this m